Document is current
Any future updates will be listed below
-
Authors
Ylinen, Venla P.
Sjöros, Tanja
Laine, Saara
Garthwaite, Taru
Norha, Jooa
Vähä-Ypyä, Henri
Löyttyniemi, Eliisa
Houttu, Noora
Laitinen, Kirsi
Kalliokoski, Kari K.
Sievänen, Harri
Vasankari, Tommi
Knuuti, Juhani
Heinonen, Ilkka HA
-
Funding
Funding for this research was provided by:
Diabetestutkimussäätiö
academy of finland
Suomen Kulttuurirahasto
Juho Vainion Säätiö
Turun Yliopistollisen Keskussairaalan Koulutus- ja Tutkimussäätiö
Yrjö Jahnssonin Säätiö
Varsinais-Suomen Sairaanhoitopiiri
Turun Yliopistosäätiö
- License Information
-
More Information
Article History
Received: 28 February 2024
Accepted: 7 October 2024
First Online: 16 October 2024
Declarations
:
: The study was conducted at the Turku PET Centre, Turku, Finland between April 2017 and March 2020 according to good clinical practice and the Declaration of Helsinki. The study was approved by the Ethics Committee of the Hospital District of Southwestern Finland (16/1801/2017) and is registered at ClinicalTrials.gov (NCT03101228, 05/04/2017).
: The participants gave their informed consent before entering the study.
: The authors declare no competing interests.
